NDC 50090-0140-01 - Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-0140
- Requested NDC
- 50090-0140-01
- Package NDCs from labels
- 50090-0140-0, 50090-0140-1, 50090-0140-8, 50090-0140-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-02-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Hydrochlorothiazide - A-S Medication Solutions | A-S Medication Solutions | 2026-02-06 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 50090-0140-0 | 2023-08-25 | Hydrochlorothiazide Tablets, USP |
| 50090-0140-1 | 2023-08-25 | Hydrochlorothiazide Tablets, USP |
| 50090-0140-8 | 2023-08-25 | Hydrochlorothiazide Tablets, USP |
| 50090-0140-0 | 2023-01-30 | Hydrochlorothiazide Tablets, USP |
| 50090-0140-1 | 2023-01-30 | Hydrochlorothiazide Tablets, USP |
| 50090-0140-8 | 2023-01-30 | Hydrochlorothiazide Tablets, USP |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-0140-0 | Hydrochlorothiazide | 30 in 1 BOTTLE | TABLET | 30 | 17 | |
| 50090-0140-1 | Hydrochlorothiazide | 100 in 1 BOTTLE | TABLET | 100 | 17 | |
| 50090-0140-8 | Hydrochlorothiazide | 200 in 1 BOTTLE | TABLET | 200 | 17 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-0140 | HYDROCHLOROTHIAZIDE TABLET [A-S MEDICATION SOLUTIONS] | 13 | Current NDC, Legacy NDC, 3 package rows | 20230920_96838fd0-ad87-4b45-b2c0-efdd1d2f3d1e.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-0140-0 | EA - Each | 50090-0140 | 5111d83c-f615-4fe4-b7a9-88553dc7d77f | 1 | 2021-05-05 |
| 50090-0140-1 | EA - Each | 50090-0140 | 54f7a2d5-3b27-4528-a957-7fb7f78a660a | 1 | 2021-05-05 |
| 50090-0140-8 | EA - Each | 50090-0140 | 2bb61eb3-a0bf-4ba4-afbe-f05dd027d9bc | 1 | 2023-10-16 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| HYDROCHLOROTHIAZIDE | ACTIVE INGREDIENT | 0J48LPH2TH | HYDROCHLOROTHIAZIDE TABLET [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| HYDROCHLOROTHIAZIDE | ACTIVE MOIETY | 0J48LPH2TH | HYDROCHLOROTHIAZIDE TABLET [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| COLLOIDAL SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | HYDROCHLOROTHIAZIDE TABLET [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| DIBASIC CALCIUM PHOSPHATE DIHYDRATE | INACTIVE INGREDIENT | O7TSZ97GEP | HYDROCHLOROTHIAZIDE TABLET [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| FD&C YELLOW NO. 6 | INACTIVE INGREDIENT | H77VEI93A8 | HYDROCHLOROTHIAZIDE TABLET [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | HYDROCHLOROTHIAZIDE TABLET [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | HYDROCHLOROTHIAZIDE TABLET [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | HYDROCHLOROTHIAZIDE TABLET [A-S MEDICATION SOLUTIONS LLC] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Sandoz Inc | f824b6ba-bd1c-41a8-8f6f-ad507b48f3e0 | 2026-07-16 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Leg Cramps PM | OYSTER SHELL CALCIUM CARBONATE, CRUDE, CAUSTICUM, MATRICARIA RECUTITA, CINCHONA OFFICINALIS BARK, COPPER, LYCOPODIUM CLAVATUM SPORE, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, TOXICODENDRON PUBESCENS LEAF, SILICON DIOXIDE, AND SULFUR | Hyland's Inc. | b0574a7e-88fa-417e-b6d5-60ced59eba47 | 2026-07-15 | Warnings | ETJ7Z6XBU4 |
| olmesartan medoxomil-hydrochlorothiazide | OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE | AvKARE | 569596a2-98f0-116a-e063-6294a90a3fa1 | 2026-07-14 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Enalapril Maleate and Hydrochlorothiazide | ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE | Sun Pharmaceutical Industries, Inc. | 7cb92cf2-46f2-4379-937c-168d230e43a4 | 2026-07-14 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Jacksons Cell Salts SILICA 12X 12 | SILICEA | Zettl Health Inc. | 5647dafc-1fff-6a25-e063-6294a90a8b4f | 2026-07-10 | ETJ7Z6XBU4 | |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | cb7b7315-0170-492c-803f-60a6e75e55da | 2026-07-08 | Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | f083c321-3170-4982-b5cd-d3fdff754857 | 2026-07-08 | Warnings, Adverse reactions | 0J48LPH2TH |
| Irbesartan and Hydrochlorothiazide | IRBESARTAN AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 88aaa2a1-13be-4f56-ace6-66e899028007 | 2026-07-07 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Golden State Medical Supply, Inc. | a85f69f5-ba97-478d-e053-2a95a90a0a97 | 2026-07-06 | Warnings, Adverse reactions | 429503 310798 197770 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | 4bc374e2-8650-41bc-8ce6-92062661bf8a | 2026-07-01 | Boxed warning, Adverse reactions | 0J48LPH2TH |
| The Cell Salt Co. Daily Blend 12 in 1 | CALC FLUOR, CALC PHOS, CALC SULPH, FERRUM PHOS, KALI MUR, KALI PHOS, KALI SULPH, MAG PHOS, NAT MUR, NAT PHOS, NAT SULPH, SILICEA | The Cell Salt Company LLC | 55826f59-acf4-7370-e063-6394a90afed7 | 2026-07-01 | Warnings | ETJ7Z6XBU4 |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | St. Mary's Medical Park Pharmacy | e1aa9682-b1ad-4a22-e053-2a95a90a0e2f | 2026-06-30 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Bambusa Stannum | BAMBUSA STANNUM | Uriel Pharmacy Inc. | a0d4d0ac-e2d2-4381-8f93-e41719521859 | 2026-06-30 | Warnings | ETJ7Z6XBU4 |
| Spironolactone and Hydrochlorothiazide | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | Safecor Health LLC | 6fa96947-f4d8-4ca4-98fd-a2c123310d83 | 2026-06-29 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 3857ac53-0435-4d68-8066-c22291414889 | 2026-06-25 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | 0de72197-607f-ef0a-e063-6394a90a8949 | 2026-06-24 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 868b1442-c412-4ee8-9798-f2408cd2249a | 2026-06-24 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | 191d5710-7b8a-0b61-e063-6394a90afd41 | 2026-06-24 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 408e797a-2cf3-4ee6-9f9b-179a8cf3d799 | 2026-06-23 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Unit Dose Solutions, Inc. | 54f027ea-0a6e-7920-e063-6394a90ab6ae | 2026-06-23 | Warnings, Adverse reactions | ANDA040907 310798 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.